EMAIL THIS PAGE TO A FRIEND

Scientific reports

Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis.


PMID 26563471

Abstract

The PP2A signaling axis regulates multiple oncogenic drivers of castration resistant prostate cancer (CRPC). We show that targeting the endogenous PP2A regulator, SET (I2PP2A), is a viable strategy to inhibit prostate cancers that are resistant to androgen deprivation therapy. Our data is corroborated by analysis of prostate cancer patient cohorts showing significant elevation of SET transcripts. Tissue microarray analysis reveals that elevated SET expression correlates with clinical cancer grading, duration of neoadjuvant hormone therapy (NHT) and time to biochemical recurrence. Using prostate regeneration assays, we show that in vivo SET overexpression is sufficient to induce hyperplasia and prostatic intraepithelial neoplasia. Knockdown of SET induced significant reductions in tumorgenesis both in murine and human xenograft models. To further validate SET as a therapeutic target, we conducted in vitro and in vivo treatments using OP449 - a recently characterized PP2A-activating drug (PAD). OP449 elicits robust anti-cancer effects inhibiting growth in a panel of enzalutamide resistant prostate cancer cell lines. Using the Pten conditional deletion mouse model of prostate cancer, OP449 potently inhibited PI3K-Akt signaling and impeded CRPC progression. Collectively, our data supports a critical role for the SET-PP2A signaling axis in CRPC progression and hormone resistant disease.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A2103
Anti-Actin, N-terminal antibody produced in rabbit, ~0.5 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4502298
Anti-PP2A-α, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB1300599
Anti-PPP2R1A (C-term) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB1300598
Anti-PPP2R1A (N-term) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB1401296
Anti-PPP2R1A antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB2103131
Anti-PPP2R1A, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB2501263
Anti-PPP2R4 (C-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1406288
Anti-PPP2R4 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA005695
Anti-PPP2R4 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1401298
Anti-PPP2R4 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB1401297
Monoclonal Anti-PPP2R1A antibody produced in mouse, clone 4E6, purified immunoglobulin, buffered aqueous solution
SAB5300403
Monoclonal Anti-PPP2R4 antibody produced in mouse, clone 4D9, purified immunoglobulin, buffered aqueous solution